Single agent activity of rhizoxin in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group.

Source:http://linkedlifedata.com/resource/pubmed/id/8562351

Download in:

View as

General Info

PMID
8562351